Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milciclib maleate phase IIa study in unresectable or metastatic hepatocellular carcinoma
2017-000144-18Phase 2Completed
- Sponsor
- Tiziana Life Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of milciclib in hepatocellular carcinoma (HCC), sponsored by Tiziana Life Sciences. Primary endpoint: Overall safety profile. Started Mar 2017; status: completed.
02
Drugs
milciclib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2017-000144-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000144-18.